Price Target: EUR (20.00) 04 April 2012 FY11 results: No surprises so far

Similar documents
Price Target: EUR (22.00)

Price Target: EUR 4.15 (3.80)

Price Target: EUR (20.60) 07 April 2011 Solid FY10 & More to come

Price Target: EUR (17.00)

Price Target: EUR 1.60 (1.50)

Price Target: EUR 5.00 (5.00)

Borussia Dortmund GmbH & Co KGaA

Price Target: EUR 1.30 (1.30)

Price Target: EUR (35.00)

Price Target: EUR (50.00)

Borussia Dortmund GmbH & Co KGaA

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

Price target: EUR (20.00) 15 August 2014 Final 2Q figures match preliminary figures

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co KGaA

Borussia Dortmund GmbH & Co. KGaA

Price Target: EUR (19.00)

PrimeCity Investment Plc

Electronics Line 3000 Ltd.

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

Reduced EPS but smart acquisition

PA Power Automation AG

BUY (previous: BUY) (previous: 77.50)

QUIRIN PRIVATBANK EQUITY RESEARCH

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

PA Power Automation AG

Highest single order in paragon s history

HOLD 51,85. (previous: Hold) (previous: 51,65)

Key ratios Sales adj. net

Buy PT EUR24,00, upside 23%

TEMPORARILY NO VALUATION. (previous: not rated)

Financials/Prime Standard

HOLD (previous: BUY) (previous: 68.00)

Research Note. Fair Value REIT-AG

The growth story continues

BUY (previous: BUY) (previous: 3.70)

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

HOLD (previous: Hold) (previous: 51.85)

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50)

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

All for One Steeb AG August 13, 2013

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

ISRA VISION Neutral

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( )

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

BUY (previous: BUY) (previous: 75.65)

18 October 2016 aventron AG. FIRST BERLIN Equity Research

Buy PT 24,00, upside 23%

Geratherm Medical AG Strong demand in Q3

Intershop Communications AG

BUY (previous: BUY) (previous: 3.40)

BDI BioEnergy Internat Buy

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

Tel.: +49 (0) Tel.: +49 (0)

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

BUY (previous: BUY) (previous: 2.20)

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

6 September 2016 aventron AG. FIRST BERLIN Equity Research

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

Advanced Vision Techn Buy

Indygotech Minerals S.A.

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

26 April 2017 aventron AG. FIRST BERLIN Equity Research

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

Leading Industrial IT set for growth

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

adesso AG MAY 31, 2012

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017

ad pepper media International N.V.

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

Advanced Vision Technology

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures &

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

adesso AG November 5, 2012

EQUINET INVESTIGATOR

Net income (after min.) >100% EPS [ ] (0.63) (0.27) >100% 0.20 (1.85)

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

11 January 2018 Deutsche Rohstoff AG. FIRST BERLIN Equity Research. Update. Bloomberg: DR0 GR Return Potential 40.2% ISIN: DE000A0XYG76

Schloss Wachenheim AG

19 December 2016 NOXXON Pharma NV. FIRST BERLIN Equity Research. Cooperation

GOING EAST & ONE YEAR AFTER

18 May 2018 Energiekontor AG. FIRST BERLIN Equity Research

ContextVision. Expecting solid results and awaiting progress update on research program

27 February 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research. Smart Meter Gateway BENEFITING FROM DIGITISATION OF HEALTH AND ENERGY MARKETS

Transcription:

Recommendation: BUY(BUY) Risk: HIGH (HIGH) Price Target: EUR 20.00 (20.00) 04 April 2012 FY11 results: No surprises so far Share price (dark) vs. TecDAX Final FY11 results: On 30 March 2011 Vectron Systems AG reported FY11 results that were in line with our expectations. In the top line sales surged yoy by 2.2% to EUR 22.5m (our estimates: EUR 22.4m). The segment POS Systems contributed more than 80% to the overall company sales while the rest was generated in the segments Software and Components. With 67.2% Germany remains Vectron s core geographic market in terms of sales contribution followed by other European markets (29.7%). Operating performance: On the operating level EBITDA declined to EUR 2.0m (our estimates: EUR 1.9m) from EUR 2.3m in previous year. The decline was driven by higher expenses related to the delays 1) in the introduction of the new stationary POS Systems and 2) rollout of the bonvito. EBIT in FY11 came in at EUR 0.6m in line with our expectations of EUR 0.6m. On the bottom line, net income amounted to EUR 74k (our estimates: EUR 23k). Operating CF amounted to EUR 720k resulting in a FCF of EUR -103k due to higher investments. Overall cash and cash equivalents declined to EUR 7.1m (incl. securities of EUR 2.0m) from EUR 7.7m in previous year. For FY11 the management will propose a dividend to EUR 0.30/share to the AGM. New estimates: Our checks with the company point to a solid start into FY12E expecting first quarter 2012 top line of EUR 5.5m with a positive operating result. However given the slower than expected market introduction of the new stationary POS Systems (up to now only POS Vario II introduced) we cut our FY12E sales forecast to EUR 25.2m (previous: EUR 27.7m). This combined with lower expenses (i.e. FY12 being the final year of annual amortization expenses of EUR 1.1m for licenses and patents) should allow for higher operating leverage. Thus we project EBIT of EUR 1.6m and EUR 2.6m, translating into respective net income of EUR 0.8m and EUR 1.5m for FY12E and FY13E. Furthermore we assume further gradual increase in DPS to EUR 0.40/share and EUR 0.60/share for FY12E and FY13E, respectively. Recommendation: We reiterate our BUY and PT EUR 20.00/share recommendation. Key data Y/E 31.12., EUR m 2009 2010 2011 2012E 2013E Total output 20.6 22.0 22.7 25.2 27.7 EBITDA 2.2 2.3 2.0 2.7 3.2 EBIT 0.8 0.9 0.6 1.6 2.6 Net result 0.1 0.3 0.1 0.8 1.5 EPS 0.07 0.20 0.05 0.52 1.03 DPS 0.00 0.30 0.30 0.40 0.60 Gross margin 60.5% 60.0% 58.8% 59.2% 59.2% EBIT margin 3.8% 4.3% 2.9% 6.5% 9.3% EV/EBITDA 7.7 7.4 8.6 6.3 5.4 EV/EBIT 21.8 18.1 26.4 10.4 6.6 P/E 180.4 59.0 n.m. 22.6 11.5 Source: CBS Research AG, Vectron Systems AG Change Sources: CBS Research AG, Bloomberg Internet: www. vectron.de WKN: A0KEXC Reuters: V3SG.DE Company profile: Share data: Share price (EUR, last closing price): Shares outstanding (in thousands): Market capitalisation (EURm): Enterprise value (EURm): Ø daily trading volume (6 m., no. of shares): Performance data: High 52 weeks (EUR): Low 52 weeks (EUR): Absolute performance: (12 months) Relative performance (vs. TecDAX): 1 month 3 months 12 months Shareholders: Jens Reckendorf Thomas Stümmler Jochen Fischer Free float Sector: Technology ISIN: DE000 A0KEXC7 Bloomberg: V3S GY Vectron Systems AG is a leading provider of intelligent POS systems for the networking of branch shops. With an installation basis of more than 100,000 POS systems, Vectron belongs to the top European manufacturers and is market leader in the German catering trade and bakery industry. 11.80 1,500 17.7 17.1 1,660 15.60 12.01-20.4% -2.4% 2.6% -10.5% 32.9% 32.9% 6.0% 28.2% Financial calendar: 1Q12 results April 2012 Author: 2011 2012E 2013E new old new old new old Sales - 22.7 25.2 27.7-27.7 EBIT - 0.6 1.6 3.9-2.6 EPS - 0.05 0.52 1.16-1.03 Veysel Taze (Analyst) Daniel Kukalj (Analyst) Close Brothers Seydler Research AG Phone: +49 (0)69-977 84 56 0 E-Mail: research@cbseydlerresearch.ag www.cbseydlerresearch.ag Please notice the information on the preparation of this document, the disclaimer, the advice regarding possible conflicts of interests, and the mandatory information required by 34b WpHG (Securities Trading Law) at the end of this document. This financial analysis in accordance with 34b WpHG is exclusively intended for distribution to individuals that buy or sell financial instruments at their own account or at the account of others in connection with their trading activities, occupation, or employment.

Profit and loss account HGB 1,000 2008 2009 2010 2011 2012E 2013E Sales 23,597 20,515 22,028 22,523 25,226 27,749 YoY grow th -7.2% -13.1% 7.4% 2.2% 12.0% 10.0% Inventory changes 19 44 5 151 0 0 Other own work capitalized 0 0 0 0 0 0 Total output 23,616 20,559 22,033 22,674 25,226 27,749 Cost of materials -8,702-8,129-8,811-9,333-10,292-11,321 as % of total output -36.8% -39.5% -40.0% -41.2% -40.8% -40.8% Gross profit 14,914 12,430 13,222 13,341 14,934 16,427 as % of total output 63.2% 60.5% 60.0% 58.8% 59.2% 59.2% Personnel expenses -4,558-4,919-5,193-5,461-5,878-6,382 as % of total output -19.3% -23.9% -23.6% -24.1% -23.3% -23.0% Other operating income 208 175 216 208 202 222 as % of total output 0.9% 0.8% 1.0% 0.9% 0.8% 0.8% Other operating expenses -5,366-5,449-5,933-6,103-6,559-7,104 as % of total output -22.7% -26.5% -26.9% -26.9% -26.0% -25.6% EBITDA 5,198 2,237 2,312 1,985 2,699 3,163 as % of total output 22.0% 10.9% 10.5% 8.8% 10.7% 11.4% Depreciation and amortization -1,385-1,451-1,369-1,336-1,057-573 as % of total output -5.9% -7.1% -6.2% -5.9% -4.2% -2.1% EBIT 3,813 785 943 649 1,643 2,590 as % of total output 16.1% 3.8% 4.3% 2.9% 6.5% 9.3% Net financial result 189 40 66 93 105 116 EBT 4,002 825 1,009 742 1,748 2,706 as % of total output 16.9% 4.0% 4.6% 3.3% 6.9% Income taxes -1,164-264 -176-123 -524-812 as % of EBT -29.1% -32.0% -17.5% -16.6% -30.0% -30.0% Other taxes (reclassified as operational) -4.0-15.1-5.9-5.9 0.0 0.0 Net income 2,834 546 827 613 1,223 1,894 as % of total output 12.0% 2.7% 3.8% 2.7% 4.8% 6.8% Profit transfer agreement -130-129 -163-175 -87 0 Jouissance right compensations -146-318 -364-364 -353-353 Net income attributable to shareholders 2,559 98 300 75 783 1,542 as % of total output 10.8% 0.5% 1.4% 0.3% 3.1% 5.6% Weighted average shares outstanding (in thousand 1,500 1,500 1,500 1,500 1,500 1,500 Basic earnings per share (EUR) 1.71 0.07 0.20 0.05 0.52 1.03 Dividend per share 1.40 0.00 0.30 0.30 0.40 0.60 Source: Vectron Systems, CBS Research AG www.cbseydlerresearch.ag Close Brothers Seydler Research AG 2

Research Schillerstrasse 27-29 60313 Frankfurt am Main Phone: +49 (0)69 977 8456-0 Roger Peeters +49 (0)69-977 8456-12 Member of the Board Roger.Peeters@cbseydlerresearch.ag Martin Decot +49 (0)69-977 8456-13 Igor Kim +49 (0)69-977 8456-15 Martin.Decot@cbseydlerresearch.ag Igor.Kim@cbseydlerresearch.ag Anna von Klopmann +49 (0)69-977 8456-10 Gennadij Kremer +49 (0)69 977 8456-23 Anna.Klopmann@cbseydlerresearch.ag Gennadij.Kremer@cbseydlerresearch.ag Daniel Kukalj +49 (0)69 977 8456-21 Ralf Marinoni +49 (0)69-977 8456-17 Daniel.Kukalj@cbseydlerresearch.ag Ralf.Marinoni@cbseydlerresearch.ag Manuel Martin +49 (0)69-977 8456-16 Felix Parmantier +49 (0)69-977 8456-22 Manuel.Martin@cbseydlerresearch.ag Felix.Parmantier@cbseydlerresearch.ag Marcus Silbe +49 (0)69-977 8456-14 Veysel Taze +49 (0)69-977 8456-18 Marcus.Silbe@cbseydlerresearch.ag Veysel.Taze@cbseydlerresearch.ag Ivo Višić +49 (0)69-977 8456-19 Ivo.Visic@cbseydlerresearch.ag Institutional Sales Schillerstrasse 27 29 60313 Frankfurt am Main Phone: +49 (0)69 9 20 54-400 Raimar Bock +49 (0)69-9 20 54-115 Head of Sales Raimar.Bock@cbseydler.com Rüdiger Eich +49 (0)69-9 20 54-119 Sule Erkan +49 (0)69-9 20 54-107 (Germany, Switzerland) Ruediger.Eich@cbseydler.com (Sales-Support) Sule.Erkan@cbseydler.com Dr. James Jackson +49 (0)69-9 20 54-113 Klaus Korzilius +49 (0)69-9 20 54-114 (UK) James.Jackson@cbseydler.com (Benelux, Germany) Klaus.Korzilius@cbseydler.com Stefan Krewinkel +49 (0)69-9 20 54-118 Markus Laifle +49 (0)69-9 20 54-120 (Execution, UK) Stefan.Krewinkel@cbseydler.com (Execution) Markus.Laifle@cbseydler.com Michael Laufenberg +49 (0)69-9 20 54-112 Bruno de Lencquesaing +49 (0)69-9 20 54-116 (Germany) Michael.Laufenberg@cbseydler.com (Benelux, France) Bruno.deLencquesaing@cbseydler.com Christopher Seedorf +49 (0)69-9 20 54-110 Janine Theobald +49 (0)69-9 20 54-106 (Sales-Support) Christopher.Seedorf@cbseydler.com (Austria, Germany) Janine.Theobald@cbseydler.com Bas-Jan Walhof +49 (0)69-9 20 54-105 (Benelux) Bas-Jan.Walhof@cbseydler.com www.cbseydlerresearch.ag Close Brothers Seydler Research AG 3

Disclaimer and statement according to 34b German Securities Trading Act ( Wertpapierhandelsgesetz ) in combination with the provisions on financial analysis ( Finanzanalyseverordnung FinAnV) This report has been prepared independently of the company analysed by Close Brothers Seydler Research AG and/ or its cooperation partners and the analyst(s) mentioned on the front page (hereafter all are jointly and/or individually called the author ). None of Close Brothers Seydler Research AG, Close Brothers Seydler Bank AG or its cooperation partners, the Company or its shareholders has independently verified any of the information given in this document. Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a security analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis. Close Brothers Seydler Research AG is a majority owned subsidiary of Close Brothers Seydler Bank AG (hereafter CBS ). However, Close Brothers Seydler Research AG (hereafter CBSR ) provides its research work independent from CBS. CBS is offering a wide range of Services not only including investment banking services and liquidity providing services (designated sponsoring). CBS or CBSR may possess relations to the covered companies as follows (additional information and disclosures will be made available upon request): a. CBS holds more than 5% interest in the capital stock of the company that is subject of the analysis. b. CBS was a participant in the management of a (co)consortium in a selling agent function for the issuance of financial instruments, which themselves or their issuer is the subject of this financial analysis within the last twelve months. c. CBS has provided investment banking and/or consulting services during the last 12 months for the company analysed for which compensation has been or will be paid for. d. CBS acts as designated sponsor for the company's securities on the basis of an existing designated sponsorship contract. The services include the provision of bid and ask offers. Due to the designated sponsoring service agreement CBS may regularly possess shares of the company and receives a compensation and/ or provision for its services. e. The designated sponsor service agreement includes a contractually agreed provision for research services. f. CBSR and the analysed company have a contractual agreement about the preparation of research reports. CBSR receives a compensation in return. g. CBS has a significant financial interest in relation to the company that is subject of this analysis. In this report, the following conflicts of interests are given at the time, when the report has been published: d,f CBS and/or its employees or clients may take positions in, and may make purchases and/ or sales as principal or agent in the securities or related financial instruments discussed in this analysis. CBS may provide investment banking, consulting, and/ or other services to and/ or serve as directors of the companies referred to in this analysis. No part of the authors compensation was, is or will be directly or indirectly related to the recommendations or views expressed. Recommendation System: Close Brothers Seydler Research AG uses a 3-level absolute share rating system. The ratings pertain to a time horizon of up to 12 months: BUY: The expected performance of the share price is above +10%. HOLD: The expected performance of the share price is between 0% and +10%. SELL: The expected performance of the share price is below 0%. Recommendation history over the last 12 months for the company analysed in this report: Date Recommendation Price at change date Price Target 04 April 2012 BUY (Update) EUR 11.80 EUR 20.00 31 October 2011 BUY (Update) EUR 10.50 EUR 20.00 04 August 2011 BUY (Update) EUR 12.82 EUR 20.00 07 April 2011 BUY (Update) EUR 14.75 EUR 20.60 25 March 2011 BUY (Update) EUR 14.62 EUR 20.60 Risk-scaling System: Close Brothers Seydler Research AG uses a 3-level risk-scaling System. The ratings pertain to a time horizon of up to 12 months: www.cbseydlerresearch.ag Close Brothers Seydler Research AG 4

LOW: The volatility is expected to be lower than the volatility of the benchmark MEDIUM: The volatility is expected to be equal to the volatility of the benchmark HIGH: The volatility is expected to be higher than the volatility of the benchmark The following valuation methods are used when valuing companies: Multiplier models (price/earnings, price/cash flow, price/book value, EV/Sales, EV/EBIT, EV/EBITA, EV/EBITDA), peer group comparisons, historical valuation approaches, discounting models (DCF, DDM), break-up value approaches or asset valuation approaches. The valuation models are dependent upon macroeconomic measures such as interest, currencies, raw materials and assumptions concerning the economy. In addition, market moods influence the valuation of companies. The figures taken from the income statement, the cash flow statement and the balance sheet upon which the evaluation of companies is based are estimates referring to given dates and therefore subject to risks. These may change at any time without prior notice. The opinions and forecasts contained in this report are those of the author alone. Material sources of information for preparing this report are publications in domestic and foreign media such as information services (including but not limited to Reuters, VWD, Bloomberg, DPA-AFX), business press (including but not limited to Börsenzeitung, Handelsblatt, Frankfurter Allgemeine Zeitung, Financial Times), professional publications, published statistics, rating agencies as well as publications of the analysed issuers. Furthermore, discussions were held with the management for the purpose of preparing the analysis. Potentially parts of the analysis have been provided to the issuer prior to going to press; no significant changes were made afterwards, however. Any information in this report is based on data considered to be reliable, but no representations or guarantees are made by the author with regard to the accuracy or completeness of the data. The opinions and estimates contained herein constitute our best judgment at this date and time, and are subject to change without notice. Possible errors or incompleteness of the information do not constitute grounds for liability, neither with regard to indirect nor to direct or consequential damages. The views presented on the covered company accurately reflect the personal views of the author. All employees of the author's company who are involved with the preparation and/or the offering of financial analyzes are subject to internal compliance regulations. The report is for information purposes, it is not intended to be and should not be construed as a recommendation, offer or solicitation to acquire, or dispose of, any of the securities mentioned in this report. Any reference to past performance should not be taken as indication of future performance. The author does not accept any liability whatsoever for any direct or consequential loss arising from any use of material contained in this report. The report is confidential and it is submitted to selected recipients only. The report is prepared for professional investors only and it is not intended for private investors. Consequently, it should not be distributed to any such persons. Also, the report may be communicated electronically before physical copies are available. It may not be reproduced (in whole or in part) to any other investment firm or any other individual person without the prior written approval from the author. The author is not registered in the United Kingdom nor with any U.S. regulatory body. It has not been determined in advance whether and in what intervals this report will be updated. Unless otherwise stated current prices refer to the closing price of the previous trading day. Any reference to past performance should not be taken as indication of future performance. The author maintains the right to change his opinions without notice, i.e. the opinions given reflect the author s judgment on the date of this report. This analysis is intended to provide information to assist institutional investors in making their own investment decisions, not to provide investment advice to any specific investor. By accepting this report the recipient accepts that the above restrictions are binding. German law shall be applicable and court of jurisdiction for all disputes shall be Frankfurt am Main (Germany). This report should be made available in the United States solely to investors that are (i) "major US institutional investors" (within the meaning of SEC Rule 15a-6 and applicable interpretations relating thereto) that are also "qualified institutional buyers" (QIBs) within the meaning of SEC Rule 144A promulgated by the United States Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the "Securities Act") or (ii) investors that are not "US Persons" within the meaning of Regulation S under the Securities Act and applicable interpretations relating thereto. The offer or sale of certain securities in the United States may be made to QIBs in reliance on Rule 144A. Such securities may include those offered and sold outside the United States in transactions intended to be exempt from registration pursuant to Regulation S. This report does not constitute in any way an offer or a solicitation of interest in any securities to be offered or sold pursuant to Regulation S. Any such securities may not be offered or sold to US Persons at this time and may be resold to US Persons only if such securities are registered under the Securities Act of 1933, as amended, and applicable state securities laws, or pursuant to an exemption from registration. This publication is for distribution in or from the United Kingdom only to persons who are authorised persons or exempted persons within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom or any order made there under or to investment professionals as defined in Section 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. This publication is for distribution in Canada only to pension funds, mutual funds, banks, asset managers and insurance companies. The distribution of this publication in other jurisdictions may be restricted by law, and persons into whose possession this publication comes should inform themselves about, and observe, any such restrictions. In particular this www.cbseydlerresearch.ag Close Brothers Seydler Research AG 5

publication may not be sent into or distributed, directly or indirectly, in Japan or to any resident thereof. Responsible Supervisory Authority: Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin, Federal Financial Supervisory Authority) Graurheindorferstraße 108 53117 Bonn and Lurgiallee 12 60439 Frankfurt Schillerstrasse 27-29 60313 Frankfurt am Main www.cbseydlerresearch.ag Tel.: 0049 - (0)69-97 78 45 60 www.cbseydlerresearch.ag Close Brothers Seydler Research AG 6